List of Excipients in API buprenorphine hydrochloride and naloxone hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing buprenorphine hydrochloride and naloxone hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | CELLULOSE, MICROCRYSTALLINE | |
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | CITRIC ACID MONOHYDRATE | |
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | CROSCARMELLOSE SODIUM | |
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | MANNITOL | |
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | MENTHOL | |
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | SILICON DIOXIDE | |
| Orexo US Inc | ZUBSOLV | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 | SODIUM CITRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing buprenorphine hydrochloride and naloxone hydrochloride
Detailed excipient profiles for buprenorphine hydrochloride and naloxone hydrochloride
Excipient focus: ACESULFAME POTASSIUM
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing ACESULFAME POTASSIUM
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing ACESULFAME POTASSIUM
Excipient focus: ALUMINUM OXIDE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing ALUMINUM OXIDE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing ANHYDROUS CITRIC ACID
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing ANHYDROUS LACTOSE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing CROSPOVIDONE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: FD&C YELLOW NO. 6
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing FD&C YELLOW NO. 6
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: LACTOSE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54868-5750 |
| >Company | >Ingredient | >NDC |
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing LACTOSE MONOHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing MAGNESIUM STEARATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing MANNITOL
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MENTHOL
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing MENTHOL
Excipient focus: POVIDONE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing POVIDONE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing POVIDONE K30
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing SODIUM CITRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM STEARYL FUMARATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing SODIUM STEARYL FUMARATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing STARCH, CORN
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-907 |
| Orexo US Inc | buprenorphine hydrochloride and naloxone hydrochloride | 54123-914 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing SUCRALOSE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing SUCRALOSE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
buprenorphine hydrochloride and naloxone hydrochloride drug variants containing WATER
buprenorphine hydrochloride and naloxone hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
